400 related articles for article (PubMed ID: 8242237)
1. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart.
Hu W; McNicholl IK; Choy PC; Man RY
Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237
[TBL] [Abstract][Full Text] [Related]
2. Similar coronary vascular effects in the rat perfused heart of platelet-activating factor structural analogues with agonist and antagonist properties.
Man RY; Kinnaird AA
Br J Pharmacol; 1995 Nov; 116(5):2359-64. PubMed ID: 8581269
[TBL] [Abstract][Full Text] [Related]
3. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart.
Hu WM; Man RY
Br J Pharmacol; 1991 Dec; 104(4):933-7. PubMed ID: 1810604
[TBL] [Abstract][Full Text] [Related]
4. Differential actions of platelet-activating factor (PAF) receptor antagonists on the vasodilator and vasoconstrictor effects of PAF in the rat perfused heart.
Hu WM; Man RY
Br J Pharmacol; 1991 Dec; 104(4):773-5. PubMed ID: 1667284
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart.
Hu W; Kinnaird AA; Man RY
Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
Piper PJ; Stewart AG
Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic pulmonary vasoconstriction in isolated blood-perfused rat lung; modulation by thromboxane A2, platelet-activating factor, cysteinyl leukotrienes and endothelin-1.
Chłopicki S; Bartuś JB; Gryglewski RJ
Pol J Pharmacol; 2002; 54(5):433-41. PubMed ID: 12593530
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor-induced coronary constriction in the isolated perfused guinea pig heart and antagonistic effects of the PAF antagonist WEB 2086.
Felix SB; Steger A; Baumann G; Busch R; Ochsenfeld G; Berdel WE
J Lipid Mediat; 1990; 2(1):9-20. PubMed ID: 2133268
[TBL] [Abstract][Full Text] [Related]
9. Actions of platelet-activating factor on isolated rat hearts.
Pugsley MK; Salari H; Walker MJ
Circ Shock; 1991 Dec; 35(4):207-14. PubMed ID: 1663843
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the coronary vascular responses to platelet-activating factor in the isolated perfused heart.
Hu WM; Choy PC; Man RY
Lipids; 1991 Sep; 26(9):700-4. PubMed ID: 1762514
[TBL] [Abstract][Full Text] [Related]
11. The synthesis, release and action of leukotrienes in the isolated, unstimulated, buffer-perfused rat heart.
Garlick PB; Mashiter GD; Di Marzo V; Tippins JR; Morris HR; Maisey MN
J Mol Cell Cardiol; 1989 Nov; 21(11):1101-10. PubMed ID: 2607544
[TBL] [Abstract][Full Text] [Related]
12. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes.
Nagase T; Ishii S; Katayama H; Fukuchi Y; Ouchi Y; Shimizu T
Am J Respir Crit Care Med; 1997 Nov; 156(5):1621-7. PubMed ID: 9372685
[TBL] [Abstract][Full Text] [Related]
13. Modulation of antigen- and ischemia-induced effects by the platelet-activating factor antagonist WEB-2086 in isolated sensitized rat hearts.
Vleeming W; Wemer J; Porsius AJ
J Cardiovasc Pharmacol; 1992; 20(5):790-9. PubMed ID: 1280743
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of leukotriene B4-induced increase in intracellular calcium ion level of human peripheral blood polymorphonuclear leukocytes by Y-24180, an antagonist of platelet-activating factor receptor.
Komatsu H; Amano M
Int J Immunopharmacol; 1997; 19(11-12):661-7. PubMed ID: 9669206
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
Chen CR; Voelkel NF; Chang SW
J Appl Physiol (1985); 1992 Nov; 73(5):1762-9. PubMed ID: 1474049
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of platelet-activating factor-induced cardiac depression in the isolated perfused rat heart.
Stahl GL; Lefer AM
Circ Shock; 1987; 23(3):165-77. PubMed ID: 2827906
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
[TBL] [Abstract][Full Text] [Related]
18. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
[TBL] [Abstract][Full Text] [Related]
19. Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4.
Piper PJ; Stewart AG
Br J Pharmacol; 1986 Jul; 88(3):595-605. PubMed ID: 3091131
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
Ammit AJ; O'Neill C
Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
